Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci
Amber A DeVries(Cedars-Sinai Medical Center), James Nicklin(United States Food and Drug Administration), Katja K.H. Aben(Radboud University Nijmegen), Ralf Bützow(Helsinki University Hospital), Linda S. Cook, Jonathan P. Tyrer(University of Cambridge), Brian Davis(Cedars-Sinai Medical Center), Ellen L. Goode(Mayo Clinic in Arizona), Alberto Luiz P. Reyes(Cedars-Sinai Medical Center), A. Heather Eliassen(Brigham and Women's Hospital), Natalia Bogdanova(Medizinische Hochschule Hannover), Simon G. Coetzee(University of Southern California), Peter A. Fasching(Universitätsklinikum Erlangen), Vanessa L. Beesley(QIMR Berghofer Medical Research Institute), Graham G. Giles(The University of Melbourne), Jenny Chang‐Claude(Universität Hamburg), Michael Friedländer(Prince of Wales Hospital), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Penny Blomfield(Royal Hobart Hospital), Joe Dennis(University of Cambridge), Ian Campbell(The University of Sydney), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Alison Davis(Australian National University), Matthias W. Beckmann(Universitätsklinikum Erlangen), Nadja Bogdanova-Markov(University of Münster), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Renée T. Fortner(Norwegian Institute of Public Health), Stephanie S. Chen(Cedars-Sinai Medical Center), Felipe Segato Dezem(St. Jude Children's Research Hospital), Jennifer A. Doherty(Cancer Prevention Institute of California), Alison H. Brand(The University of Sydney), Hoda Anton‐Culver(University of California, Irvine), Yee Leung(King Edward Memorial Hospital), Peter Grant(The University of Melbourne), Pei-Chen Peng(Cedars-Sinai Medical Center), Jacek Gronwald(International Hereditary Cancer Center), G Chevenix-Trench(University of California, Los Angeles), Alicia Beeghly‐Fadiel(University of Helsinki), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Jasmine Plummer(St. Jude Children's Research Hospital), C.A. Nagle(University of British Columbia), Andreas Obermair(Royal Brisbane and Women's Hospital)
Cited by 13
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k